Times Medicament Private Limited

Nindanib 150mg capsule consists of the active ingredient Nintedanib and Nindanib 150 substitute have different substitutes like Nintena 150. It belongs to the medication class known as tyrosine kinase inhibitors. It treats idiopathic pulmonary fibrosis, chronic fibrosing interstitial lung disease, and systemic sclerosis-associated interstitial lung disease. Talk to your physician if you are on blood thinning medications or have recently undergone surgery. Use effective contraception while receiving this capsule and continue to use it for three months, even after receiving the final dose. Consult your doctor for effective contraception because the birth control pills may not work properly on women.  

Palbrex 125mg Capsule is a targeted therapy containing the active constituent palbociclib. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic  breast cancer. The common side effects that are likely to be associated with Palbrex 125mg Capsule are nausea, vomiting, diarrhoea, tiredness, hair loss, nose bleed, decreased appetite, low blood cell counts,  changes in taste, dry eye, blurred vision, and increased tearing.